Osivax’s Post

Euronext was thrilled to sponsor the 24th edition of Bio€quity Europe, held from 12 to 14 May in San Sebastián, Spain. This year's event was highlighted by #Euronext's opening bell ceremony on the second day, which set the stage for a fantastic exchange of ideas and insights among participants. Sophie Stegen, Head of Listing at #EuronextBrussels, also joined an expert panel to discuss the key factors that biotech companies need to consider in order to attract investor attention in a buyers' market. For over two decades, Bio€quity Europe has served as a premier platform for CEOs and investors to connect, collaborate, and engage in discussions within the biotech industry. With over 120 Healthtech companies listed on our markets, Euronext proudly stands as the leading European stock exchange in this sector. We would like to express our gratitude to all the attendees and event organisers at Bio€quity for their contributions in making this year's event a success. For more information: https://lnkd.in/eWsgzae7 #BioEquityEurope #CapitalMarkets #Biotech 

This year the LSX Nordic Congress is bringing more opportunities than ever before to connect, collaborate, and form lasting relationships with life science innovators and leaders across Northern Europe, as well as international investors! This year's agenda will be looking at the growth and internationalisation of the Nordic region and its transformation into a global hub of innovation. 90+ speakers have already been confirmed including global heads at AstraZeneca, Novo Nordisk, and Genmab and international investors from Forbion, Sunstone Life Science Ventures, and Novo Venture. You can also get involved in: • Networking Drinks: Providing you with the opportunity to informally network and build relationships with key figures in the Northern European life science community • Qualified partnering: Pre-arrange private meetings with your preferred participants ahead of the event with our user-friendly conference partnering platform. Search, filter, and auto-schedule to build your personal itinerary with ease • Showcases: These sessions are designed to highlight Nordic innovation and investment opportunities from across the region. If you're fundraising there's no better place to be, you'll have access to 150+ specialist life science investors Secure the best rate, and book before 28 June to save up to €650. Find out more - https://lnkd.in/eCkHc4Rq #LSXNordic #Biotech #Medtech #healthtech #pharma #investors

Words of wisdom from one of our key speakers Klaudia Eriksson Philipp from Pfizer for startups. What should you consider when you're looking to scale? Read her insights from the panel below!

Exciting News: The MAP Group expands its European market access expertise with SKC acquisition We are pleased to announce that The MAP Group has made a significant advancement in fortifying our presence across Europe by acquiring SKC Beratungsgesellschaft mbH, a preeminent German consultancy in market access, pricing, and reimbursement. This acquisition allows us to expand our team, enhance our expertise, and increase our footprint in one of Europe’s most vital markets. SKC, established in 2005 and headquartered in Hannover, Germany, brings invaluable experience and insight, aiding companies in the pharma, biotech, medtech, and digital health sectors with intricate strategic matters. Steve Glass, CEO of The MAP Group, expressed enthusiasm regarding the acquisition: “With the integration of the seasoned and skilled team from SKC, we further our mission to ensure patient access to transformative therapies in Europe and beyond. As the implications of the imminent EU-HTA loom, this acquisition represents a critical step in expanding our pan-European presence and supporting our clients in a constantly evolving landscape, with a global perspective and essential local expertise.” We eagerly anticipate collaborating to achieve even greater success for our clients, making a significant impact on healthcare across Europe! Read the full press release here: https://lnkd.in/evRnpEmd #growth #patientaccess #marketaccess #europe #team

Excellent opportunity to meet with Novotech experts, at OCT UK & Ireland. Are you looking to: 📍Expand your reach and accelerate clinical trials? 📍Access diverse patient populations in the Asia-Pacific region (APAC)? 📍Gain insights from clinical trial experts? Then join us for our exclusive presentation: "Unlocking APAC's Potential to Enhance Your Clinical Trial Programme"! In this presentation, we'll delve into the importance of APAC in clinical trials and explore how you can leverage the region's unique strengths to optimize your development timelines and strategies. Click the link below and schedule a meeting. https://lnkd.in/dtnCedRU #APAC #clinicaltrials #clinicaldevelopment

Swiss Biotech Day is just around the corner 👍 The platform with professionals in the life sciences community ✅ ... for networking, engaging discussions, exploring progresses in research, manufacturing, data, financing ✅ ... you name it ✅ Swiss Biotech Association #swissbiotechday  #swissbiotechday2024

Are you attending the Boston Business Journal’s Biotech in Boston: Leading the Way in Life Sciences event tomorrow? If so, my colleagues and I look forward to meeting you and showcasing our innovative immigration solutions for biotech clients. #BBJ #BAL #immigrationlaw

Roughly 7.5 weeks until we gather in Sintra, Portugal. Nearly 1,000 senior decision-makers, investors, and strategics. This event will be special. Here are a few updates worth getting excited about if you’re planning to attend LSI Europe ‘24: 1. This is the best investor-to-startup ratio we’ve ever had at an LSI event The numbers are terrific and the table is set for connections to happen and deals to get done. Partnering opens in less than 30 days so check out the investor attendees on our site and start doing your diligence early. 2. Another new improvement to our partnering process to help you book more high-quality meetings We’re profiling presenting companies earlier this year so that investors and strategics have more information available to reach out and book meetings with you while also ruling out meetings that they know don’t contribute to their thesis or vision. This means more quality meetings for everyone — it’s a win-win-win for everyone in Portugal. 3. The full agenda is available now (link in comments) + three sessions that caught my attention already - Amber Therapeutics: Landmark $100M Series A, and the Future of Neuromodulation for Mixed Urinary Incontinence - Neuromodulation: Challenges, Ethics, and Unmet Needs Driving Innovation and Investment - Raising Capital From Family Offices ========================== Are you considering joining us? Want to talk through it with our team to get a better idea? Give us a ring or message on LinkedIn and we will make time for you.

Exciting News from NIMBLE Diagnostics! We are thrilled to announce that NIMBLE Diagnostics has been awarded the Best MedTech Startup of the Year by the #EIC! 🏆 A few weeks ago, our CEO Oriol Iborra showcased our WAEVE System at an ePitching competition among top MedTech startups recognized by the #EIC Accelerator. This recognition further validates our mission to introduce the world's first non-invasive technology for detecting defects in coronary stents, aiming to enhance care for #cardiovascular patients. Check out the post below to learn more and stay tuned for more exciting updates coming soon! #MedTechInnovation #HealthcareTechnology #EICAccelerator #CardiovascularHealth

Exciting News: The MAP Group expands its European market access expertise with SKC acquisition We are pleased to announce that The MAP Group has made a significant advancement in fortifying our presence across Europe by acquiring SKC Beratungsgesellschaft mbH, a preeminent German consultancy in market access, pricing, and reimbursement. This acquisition allows us to expand our team, enhance our expertise, and increase our footprint in one of Europe’s most vital markets. SKC, established in 2005 and headquartered in Hannover, Germany, brings invaluable experience and insight, aiding companies in the pharma, biotech, medtech, and digital health sectors with intricate strategic matters.   Steve Glass, CEO of The MAP Group, expressed enthusiasm regarding the acquisition: “With the integration of the seasoned and skilled team from SKC, we further our mission to ensure patient access to transformative therapies in Europe and beyond. As the implications of the imminent EU-HTA loom, this acquisition represents a critical step in expanding our pan-European presence and supporting our clients in a constantly evolving landscape, with a global perspective and essential local expertise.”   We eagerly anticipate collaborating to achieve even greater success for our clients, making a significant impact on healthcare across Europe! Read the full press release here: https://lnkd.in/evRnpEmd #growth #patientaccess #marketaccess #europe #team